---
figid: PMC10307684__gr3
pmcid: PMC10307684
image_filename: gr3.jpg
figure_link: /pmc/articles/PMC10307684/figure/fig3/
number: Fig. 3
figure_title: ''
caption: Effect of Wedelolactone on Pro-inflammatory cytokines [(a) IL-1α, (b) IL-1β,
  (c) IL-2, (d) IL-6, (e) TNF-α, (f) IFNγ, (g) STAT3, (h) CCL-5 and (i) NFκB)] of
  DSS induced colitis. Group I-Vehicle control, Group II-DSS control, Group III-Wedelolactone
  treatment group (50 mg/kg), Group IV-Wedelolactone treatment group (100 mg/kg).
  The values are expressed as Mean ± SEM (n = 6). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001,
  Data was analyzed by One-Way Analysis of Variance (ANOVA) followed by Dunnett's
  test.
article_title: 'Anti-inflammatory effect of wedelolactone on DSS induced colitis in
  rats: IL-6/STAT3 signaling pathway.'
citation: T. Prakash, et al. J Ayurveda Integr Med. 2023 Mar-Apr;14(2):100544.
year: '2023'

doi: 10.1016/j.jaim.2022.100544
journal_title: Journal of Ayurveda and Integrative Medicine
journal_nlm_ta: J Ayurveda Integr Med
publisher_name: Elsevier

keywords:
- Wedelolactone
- Dextran sulphate sodium
- Colitis
- Pro-inflammatory cytokines
- IL-6/STAT3 pathway

---
